Labshake search
Citations for Haematologic Technologies :
1 - 6 of 6 citations for Chemokine C X C Motif Ligand 3 CXCL3 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... a calcium independent ligand of PS (200nM, 15 min, RT; Haematologic Technologies, Essex Junction, USA).29,30 Sufficient blocking concentrations of Lactadherin were assessed via Calibrated Automated Thrombogram (CAT ...
-
bioRxiv - Immunology 2021Quote: The effect of FH on protein C (PC) activation was monitored by combining FH (0.5-125nM) with 1.75nM thrombin and 200nM PC (Haematologic Technologies, Inc., USA) in the absence or presence of 10nM soluble recombinant TM (R&D Systems/Biotechne ...
-
bioRxiv - Bioengineering 2022Quote: ... Human coagulation Factor X (hFX) (Haematologic Technologies) was added to diluted vectors at a final concentration of 8 μg/mL ...
-
bioRxiv - Microbiology 2021Quote: ... Factor X and prothrombin-deficient plasma were obtained from Haematologic Technologies (#FX-ID and #FII-ID). Russell’s Viper Venom test was performed with 10 µg/ml snake venom from Vipera russelli (RVV ...
-
bioRxiv - Pathology 2020Quote: ... membranes were incubated overnight at 1:2000 in primary antibody (Anti-murine Prothrombin, Haematologic Technologies Inc, Essex Junction, VT) followed by corresponding secondary antibody conjugated to horseradish peroxidase ...
-
bioRxiv - Pathology 2020Quote: ... ELISA and immunoblot antibodies were validated using species-specific positive (purified species-specific protein; Haematologic Technologies, Inc, Essex Juntion, VT) and non-specific protein negative controls ...